Delivery Order SPE2DB24D3015-SPE2DB26FFWSM
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order on September 16, 2025, by the Defense Logistics Agency (DLA) for Rexulti 2 mg tablets in quantities of 30 units, with a ceiling value of $4,608.06. The contract utilizes firm fixed price pricing and is scheduled for ultimate completion by September 17, 2025. This delivery order was issued without a set-aside designation, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,195.59 by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Rexulti 2 mg tablets (30-count packages). The contract carries a firm fixed price structure with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 10, 2025, with performance conducted from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,033.39 by the Defense Logistics Agency for the supply of Rexulti 2 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,720.78 to AmerisourceBergen Drug Corp for the supply of Rexulti (brexpiprazole) 2 mg tablets in a quantity of 30 units. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 1, 2025, for the supply of Rexulti 2 mg tablets (30-count units). This competitively awarded, non-set-aside contract carries a ceiling value of $13,820.61 and operates under firm fixed pricing, with an ultimate completion date of July 2, 2025. The place of performance is located at AmerisourceBergen's corporate office in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Rexulti 0.5 mg tablets (30-count packages) valued at $14,929.95 with a firm fixed price structure. This delivery order represents a competitive award with no set-aside designation and is set to conclude by August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work from its Corporate Office...
- The Defense Logistics Agency awarded a $59,725.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units), with an ultimate completion date of June 2, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.99 million and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $8,122.46 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was issued on October 17, 2025, with an ultimate completion date of October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the performer of record for this delivery order. This award represents a child contract action under the company's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for REXULTI 3 MG tablets (30-count supply) with a ceiling value of $22,083.84. This firm fixed price delivery order represents a non-competitive set-aside contract and is scheduled for ultimate completion by August 8, 2025. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $10,744.78 by the Defense Logistics Agency (DLA) for the supply of Rexulti 4 mg tablets in a 30-count package. This non-competitive, firm fixed-price delivery order was awarded on May 30, 2025, with an ultimate completion date of June 2, 2025. The contract is being performed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...